Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017, Article ID 5469597, 9 pages
https://doi.org/10.1155/2017/5469597
Research Article

Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer

1Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China
2Department of Gastroenterology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, 299 Qingyang Road, Wuxi 214023, China
3Department of Gastroenterology, The First People’s Hospital of Lianyungang, 182 North Tongguan Road, Lianyungang 222002, China
4Lab of Metabolomics, Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjia Avenue, Gulou District, Nanjing 210009, China

Correspondence should be addressed to Jiye Aa; nc.ude.upc@aeyij and Lianzhen Yu; moc.621@nehznaily

Received 21 July 2016; Accepted 5 January 2017; Published 20 April 2017

Academic Editor: Tetsuro Setoyama

Copyright © 2017 Xianlan Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Chen, R. Zheng, S. Zhang et al., “Report of cancer incidence and mortality in China, 2010,” Annals of Translational Medicine, vol. 2, no. 7, p. 61, 2014. View at Publisher · View at Google Scholar
  2. E. Kim, S. Koroukian, and C. R. Thomas Jr, “Conditional survival of esophageal cancer: an analysis from the SEER registry (1988-2011),” Journal of Thoracic Oncology, vol. 10, no. 10, pp. 1490–1497, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Wen, L. Zhang, X. Wang et al., “A 5.5-year surveillance of esophageal and gastric cardia precursors after a population-based screening in China,” Journal of Gastroenterology and Hepatology, vol. 30, no. 12, pp. 1720–1725, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. J. K. Nicholson and J. C. Lindon, “Systems biology: metabonomics,” Nature, vol. 455, no. 7216, pp. 1054–1056, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. DeBerardinis, J. J. Lum, G. Hatzivassiliou, and C. B. Thompson, “The biology of cancer: metabolic reprogramming fuels cell growth and proliferation,” Cell Metabolism, vol. 7, no. 1, pp. 11–20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. K. Nicholson, J. Connelly, J. C. Lindon, and E. Holmes, “Metabonomics: a platform for studying drug toxicity and gene function,” Nature Reviews Drug Discovery, vol. 1, no. 2, pp. 153–161, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. W. M. Claudino, A. Quattrone, L. Biganzoli, M. Pestrin, I. Bertini, and A. Di Leo, “Metabolomics: available results, current research projects in breast cancer, and future applications,” Journal of Clinical Oncology, vol. 25, no. 19, pp. 2840–2846, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Yu, J. Aa, J. Xu et al., “Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry,” Journal of Gastroenterology and Hepatology, vol. 26, no. 8, pp. 1290–1297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. K. Pasikanti, K. Esuvaranathan, Y. Hong et al., “Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry,” Journal of Proteome Research, vol. 12, no. 9, pp. 3865–3873, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Mondal, D. Roy, J. Camacho-Pereira et al., “HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer,” Oncotarget, vol. 6, no. 32, pp. 33705–33719, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Bro, M. H. Kamstrup-Nielsen, S. B. Engelsen et al., “Forecasting individual breast cancer risk using plasma metabolomics and biocontours,” Metabolomics, vol. 11, no. 5, pp. 1376–1380, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Li, H. Liu, Y. Jin, S. Lin, Z. Cai, and Y. Jiang, “Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice,” Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences, vol. 879, no. 24, pp. 2369–2375, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. V. W. Wong, G. L. Wong, W. C. Chu et al., “Hepatitis B virus infection and fatty liver in the general population,” Journal of Hepatology, vol. 56, no. 3, pp. 533–540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Zhang, H. Sun, and X. Wang, “Power of metabolomics in biomarker discovery and mining mechanisms of obesity,” Obesity Reviews, vol. 14, no. 4, pp. 344–349, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Chen, Z. Ma, L. Min et al., “Biomarker identification and pathway analysis by serum metabolomics of lung cancer,” BioMed Research International, vol. 2015, Article ID 183624, p. 9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. G. A. Gowda, S. Zhang, H. Gu, V. Asiago, N. Shanaiah, and D. Raftery, “Metabolomics-based methods for early disease diagnostics,” Expert Review of Molecular Diagnostics, vol. 8, no. 5, pp. 617–633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Pan and D. Raftery, “Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics,” Analytical and Bioanalytical Chemistry, vol. 387, no. 2, pp. 525–527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Jin, F. Qiao, L. Chen, C. Lu, L. Xu, and X. Gao, “Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma,” Journal of Proteome Research, vol. 13, no. 9, pp. 4091–4103, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. V. W. Davis, D. E. Schiller, D. Eurich, and M. B. Sawyer, “Urinary metabolomic signature of esophageal cancer and Barrett’s esophagus,” World Journal of Surgical Oncology, vol. 10, p. 271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. T. C. Burch, G. Isaac, C. L. Booher et al., “Comparative metabolomic and lipidomic analysis of phenotype stratified prostate cells,” PLoS One, vol. 10, no. 8, p. e0134206, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Jin, S. J. Yun, P. Jeong, I. Y. Kim, W. J. Kim, and S. Park, “Diagnosis of bladder cancer and prediction of survival by urinary metabolomics,” Oncotarget, vol. 5, no. 6, pp. 1635–1645, 2014. View at Publisher · View at Google Scholar
  22. C. Denkert, J. Budczies, W. Weichert et al., “Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover,” Molecular Cancer, vol. 7, p. 72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Warburg, “On the origin of cancer cells,” Science, vol. 123, no. 3191, pp. 309–314, 1956. View at Publisher · View at Google Scholar
  24. J. Y. Aa, L. Z. Yu, M. Sun et al., “Metabolic features of the tumor microenvironment of gastric cancer and the link to the systemic macroenvironment,” Metabolomics, vol. 8, no. 1, pp. 164–173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. R. M. Maria, W. F. Altei, A. D. Andricopulo et al., “Characterization of metabolic profile of intact non-tumor and tumor breast cells by high-resolution magic angle spinning nuclear magnetic resonance spectroscopy,” Analytical Biochemistry, vol. 488, pp. 14–18, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Halama, B. S. Guerrouahen, J. Pasquier et al., “Metabolic signatures differentiate ovarian from colon cancer cell lines,” Journal of Translational Medicine, vol. 13, p. 223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Zhang, L. Liu, S. Wei et al., “Metabolomics study of esophageal adenocarcinoma,” The Journal of Thoracic and Cardiovascular Surgery, vol. 141, no. 2, pp. 469–475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Wang, J. Chen, L. Chen et al., “1H-NMR based metabonomic profiling of human esophageal cancer tissue,” Molecular Cancer, vol. 12, p. 25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. C. M. Metallo, P. A. Gameiro, E. L. Bell et al., “Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia,” Nature, vol. 481, no. 7381, pp. 380–384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Yuneva, N. Zamboni, P. Oefner, R. Sachidanandam, and Y. Lazebnik, “Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells,” The Journal of Cell Biology, vol. 178, no. 1, pp. 93–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. C. A. Opitz, U. M. Litzenburger, U. Opitz et al., “The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells,” PLoS One, vol. 6, no. 5, p. e19823, 2011. View at Publisher · View at Google Scholar · View at Scopus